 Co-Diagnostics, Inc. NASDAQ:CODX has announced that its Logix Smart SARS-CoV-2 DS Direct Saliva test has obtained regulatory authorization to be sold as an in vitro diagnostic IVD for the diagnosis of coronavirus COVID-19 in markets that accept CE markings. The company noted that the test is available now for purchase from its Utah-based ISO-13485:2016 certified facility. 